Personal Diligence Shapes VC Bets on This Backed CrowdStrike
In 2026, a growing number of VCs weigh founders’ families and mentors as part of the investment thesis, a trend chang...
A concise checklist to verify inputs, validate assumptions, and confirm your zero based budget remains aligned with priorities.
17,617 articlesIn 2026, a growing number of VCs weigh founders’ families and mentors as part of the investment thesis, a trend chang...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Pershing Square seeks an NYSE debut for both its closed-end fund and parent, targeting a $5-$10 billion raise and a B...
tesla’s optimus robot seriously becomes the focal point for investors debating TSLA stock as the company retools prod...
As 2026 AI demand shifts, investors weigh TSMC and AMD on who can sustain capacity, pricing power, and growth. This p...
As Berkshire Hathaway transitions from Buffett to Greg Abel, Abel makes a bold opening move. This piece explains the ...
A bold contrarian wager on semiconductors has underperformed as AI demand sustains a rally. Leveraged, daily-reset fu...
Explore how Solo Brands (SBDS) 2025 could unfold, with a clear view of revenue drivers, margins, and strategic bets. ...
Dairy Queen's leader says Buffett taught him a simple truth: passion for the mission matters more than being the smar...
BlackRock signals that a new youth-savings framework, dubbed Trump Accounts, could help jump-start saving for educati...
Chewy just popped. stock momentum followed a better-than-expected 2026 outlook, even as Q4 growth stayed modest. This...
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...